Silliker Receives NIH/NCCAM Grant
Silliker, Inc. (Homewood, IL) has received a grant to study the allicin bioavailability of garlic products, the company announced on November 24.
HOMEWOOD, IL-Silliker, Inc. has received a grant to study the allicin bioavailability of garlic products, the company announced on November 24.
Allicin is the main, active compound of garlic that is known to provide the most health benefits.
The $599,500 award was been granted by the National Institute of Health and the National Center for Complementary and Alternative Medicine (NIH/NCCAM; Bethesda, MD), and will cover a minimum two-year period.
Most garlic supplements have allicin levels of about 3-15 percent, compared to 100 percent in raw garlic. Without clinical research, however, it is difficult to make advancements in the field.
The conclusions of the study, Silliker stated, will address three main goals:
“1) An understanding of what type of supplements should be used in a clinical trial and in what form it should be consumed.
2) How results can be extrapolated to crushed raw garlic.
3) Provide supplement manufacturers with a correct standard for the design and evaluation of garlic supplements."
This is the third grant Silliker has received from NIH and NCCAM.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
